CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Alessia Ligresti - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Alessia Ligresti

OPENALEX: A5068513157↗ORCID: 0000-0003-1787-3900↗

Affiliations

Organizations

Istituto di Chimica Biomolecolareauthorship · IT National Research Councilauthorship · IT

Public evidence

3 connected articles

Motifs in Natural Products as Useful Scaffolds to Obtain Novel Benzo[<i>d</i>]imidazole-Based Cannabinoid Type 2 (CB2) Receptor Agonists.2023 · PubMed Central Open Access New Coumarin Derivatives as Cholinergic and Cannabinoid System Modulators.2021 · Europe PMC Biosynthesis of the Novel Endogenous 15-Lipoxygenase Metabolites <i>N</i>-13-Hydroxy-octodecadienoyl-ethanolamine and 13-Hydroxy-octodecadienoyl-glycerol by Human Neutrophils and Eosinophils.2021 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.